ArticleBioMed research international2026
Effect of Maternal Age on the Proliferation and Osteogenic Differentiation of Human Umbilical Cord Stem Cells.
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Human umbilical cord (UC), once regarded as medical waste, has emerged as a valuable and ethically acceptable source of mesenchymal stem cells (MSCs) due to its high availability and regenerative potential. Among UC-derived tissues, Wharton's jelly (WJ) is particularly rich in MSCs, making it a promising candidate for cell-based therapies; however, factors influencing the biological properties of these cells, including maternal age, remain insufficiently understood. This study is aimed at evaluating the impact of maternal age on proliferation and differentiation of MSCs from the WJ of human UC. In this comparative study, UC from healthy mothers grouped into five age groups (25-45 years old) were collected and treated to assess their proliferation and differentiation in vitro. The results indicate that the rate of proliferation and osteogenic differentiation are inversely associated to maternal age. The maternal age effect is important for clinical applications based on the use of MSCs from WJ.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.